Skip to main content
SpringerLink
Log in

Biopharmaceutical Characterization of the Telomerase Inhibitor BRACO19

  • Short Communication
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Purpose

To characterize the telomerase inhibitor and G-quadruplex stabilizing substance 9-[4-(N,N-dimethylamino)phenylamino]-3,6-bis (3-pyrrolodino-propionamido) acridine × 3HCl (BRACO19) in terms of biopharmaceutical properties such as solubility, protein binding, interaction with membrane lipids, cytotoxicity, and permeability across pulmonary epithelial cells.

Methods

Protein binding and interaction with membrane lipids were investigated by two high-performance liquid chromatography methods with immobilized human serum albumin and immobilized phosphatidylcholine, respectively. Cytotoxicity (methyl–thiazolyl–tetrazolium assay) and transport studies were performed with the bronchial cell lines 16HBE14o− and Calu-3, primary human alveolar epithelial cells, and the intestinal cell line Caco-2. Transport experiments were also done in the presence of cyclosporin A (10 μM) and tetraethylammonium chloride (5 mM) and at low temperature (4°C).

Results

BRACO19 has good solubility of at least 2 mg/mL in water and in physiological buffers of pH 7.4 and below. Protein binding to human serum albumin was 38%. No interaction with membrane lipids could be found. Cytotoxicity in 16HBE14o−, Calu-3, and human alveolar epithelial cells was in the range of IC50 = 3.5 to 13.5 μM. Caco-2 cells were not affected at concentrations up to 50 μM. No transport of BRACO19 was detected across either cell monolayer in absorptive direction. In secretory direction, permeability was very low, with P app values in the range of 0.25×10−7 to 0.98×10−7 cm/s for all epithelial cell cultures tested. The transport was not influenced by cyclosporin A or tetraethylammonium chloride or at 4°C, indicating that no efflux/influx systems or active transport are involved.

Conclusions

From these results, we conclude that the very poor permeability of BRACO19 is its main biopharmaceutical limitation. Further applications will require a suitable formulation to warrant adequate delivery across cellular barriers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

AB:

apical to basolateral (transport/direction)

BA:

basolateral to apical (transport/direction)

hAEpC:

primary human alveolar epithelial cells

HSA:

human serum albumin

IAM:

immobilized artificial membrane

NSCLC:

non-small cell lung cancer

P-gp:

P-glycoprotein

TEAC:

tetraethylammonium chloride

References

  1. E. H. Blackburn (2005) ArticleTitleTelomeres and telomerase: their mechanisms of action and the effects of altering their functions FEBS Lett. 579 859 Occurrence Handle15680963 Occurrence Handle1:CAS:528:DC%2BD2MXosVOisQ%3D%3D Occurrence Handle10.1016/j.febslet.2004.11.036

    Article  PubMed  CAS  Google Scholar 

  2. J. W. Shay W. E. Wright (2005) ArticleTitleSenescence and immortalization: role of telomeres and telomerase Carcinogenesis 26 867–874 Occurrence Handle15471900 Occurrence Handle1:CAS:528:DC%2BD2MXjsFOnu7Y%3D Occurrence Handle10.1093/carcin/bgh296

    Article  PubMed  CAS  Google Scholar 

  3. M. Misawa T. Tauchi G. Sashida A. Nakajima K. Abe J. H. Ohyashiki K. Ohyashiki (2002) ArticleTitleInhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells Int. J. Oncol. 21 1087–1092 Occurrence Handle12370759 Occurrence Handle1:CAS:528:DC%2BD38XosFSrtr0%3D

    PubMed  CAS  Google Scholar 

  4. K. Piotrowska E. Kleideiter T. E. Mürdter S. Taetz C. Baldes U. Schaefer C. M. Lehr U. Klotz (2005) ArticleTitleOptimization of the TRAP assay to evaluate specificity of telomerase inhibitors Lab. Invest. 85 IssueID12 1565–1569 Occurrence Handle16170334 Occurrence Handle1:CAS:528:DC%2BD2MXht1aqsrzP

    PubMed  CAS  Google Scholar 

  5. S. M. Gowan J. R. Harrison L. Patterson M. Valenti M. A. Read S. Neidle L. R. Kelland (2002) ArticleTitleA G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity Mol. Pharmacol. 61 1154–1162 Occurrence Handle11961134 Occurrence Handle1:CAS:528:DC%2BD38XjtlGlu78%3D Occurrence Handle10.1124/mol.61.5.1154

    Article  PubMed  CAS  Google Scholar 

  6. A. M. Burger F. Dai C. M. Schultes A. P. Reszka M. J. Moore J. A. Double S. Neidle (2005) ArticleTitleThe G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function Cancer Res. 65 1489–1496 Occurrence Handle15735037 Occurrence Handle1:CAS:528:DC%2BD2MXhsFKqtLs%3D Occurrence Handle10.1158/0008-5472.CAN-04-2910

    Article  PubMed  CAS  Google Scholar 

  7. A. L. Cozens M. J. Yezzi K. Kunzelmann T. Ohrui L. Chin K. Eng W. E. Finkbeiner J. H. Widdicombe D. C. Gruenert (1994) ArticleTitleCFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells Am. J. Respir. Cell Mol. Biol. 10 38–47 Occurrence Handle7507342 Occurrence Handle1:CAS:528:DyaK2cXis1Kms7w%3D

    PubMed  CAS  Google Scholar 

  8. B. Forbes A. Shah G. P. Martin A. B. Lansley (2003) ArticleTitleThe human bronchial epithelial cell line 16HBE14o− as a model system of the airways for studying drug transport Int. J. Pharm. 257 161–167 Occurrence Handle12711171 Occurrence Handle1:CAS:528:DC%2BD3sXjtVemsrc%3D Occurrence Handle10.1016/S0378-5173(03)00129-7

    Article  PubMed  CAS  Google Scholar 

  9. B. I. Florea M. L. Cassara H. E. Junginger G. Borchard (2003) ArticleTitleDrug transport and metabolism characteristics of the human airway epithelial cell line Calu-3 J. Control. Release 87 131–138 Occurrence Handle12618029 Occurrence Handle1:CAS:528:DC%2BD3sXhsFOlsrc%3D Occurrence Handle10.1016/S0168-3659(02)00356-5

    Article  PubMed  CAS  Google Scholar 

  10. K. A. Foster M. L. Avery M. Yazdanian K. L. Audus (2000) ArticleTitleCharacterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery Int. J. Pharm. 208 1–11 Occurrence Handle11064206 Occurrence Handle1:CAS:528:DC%2BD3cXosVGjsbw%3D Occurrence Handle10.1016/S0378-5173(00)00452-X

    Article  PubMed  CAS  Google Scholar 

  11. K. J. Elbert U. F. Schaefer H. J. Schafers K. J. Kim V. H. Lee C. M. Lehr (1999) ArticleTitleMonolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies Pharm. Res. 16 601–608 Occurrence Handle10349999 Occurrence Handle1:CAS:528:DyaK1MXjt1yisbk%3D Occurrence Handle10.1023/A:1018887501927

    Article  PubMed  CAS  Google Scholar 

  12. S. Fuchs A. J. Hollins M. Laue U. F. Schaefer K. Roemer M. Gumbleton C. M. Lehr (2003) ArticleTitleDifferentiation of human alveolar epithelial cells in primary culture: morphological characterization and synthesis of caveolin-1 and surfactant protein-C Cell Tissue Res. 311 31–45 Occurrence Handle12483282 Occurrence Handle10.1007/s00441-002-0653-5

    Article  PubMed  Google Scholar 

  13. P. Artursson K. Palm K. Luthman (2001) ArticleTitleCaco-2 monolayers in experimental and theoretical predictions of drug transport Adv. Drug Deliv. Rev. 46 27–43 Occurrence Handle11259831 Occurrence Handle1:CAS:528:DC%2BD3MXitVOhs7s%3D Occurrence Handle10.1016/S0169-409X(00)00128-9

    Article  PubMed  CAS  Google Scholar 

  14. R. J. Harrison J. Cuesta G. Chessari M. A. Read S. K. Basra A. P. Reszka J. Morrell S. M. Gowan C. M. Incles F. A. Tanious W. D. Wilson L. R. Kelland S. Neidle (2003) ArticleTitleTrisubstituted acridine derivatives as potent and selective telomerase inhibitors J. Med. Chem. 46 4463–4476 Occurrence Handle14521409 Occurrence Handle1:CAS:528:DC%2BD3sXnt1KmsrY%3D Occurrence Handle10.1021/jm0308693

    Article  PubMed  CAS  Google Scholar 

  15. C. Ehrhardt K. J. Kim C. M. Lehr (2005) ArticleTitleIsolation and culture of human alveolar epithelial cells Methods Mol. Med. 107 207–216 Occurrence Handle15492374 Occurrence Handle1:CAS:528:DC%2BD2MXjt1aqtA%3D%3D

    PubMed  CAS  Google Scholar 

  16. C. Ehrhardt C. Kneuer C. Bies C. M. Lehr K. J. Kim U. Bakowsky (2005) ArticleTitleSalbutamol is actively absorbed across human bronchial epithelial cell layers Pulm. Pharmacol. Ther. 18 165–170 Occurrence Handle15707849 Occurrence Handle1:CAS:528:DC%2BD2MXhtFOltrc%3D Occurrence Handle10.1016/j.pupt.2004.11.007

    Article  PubMed  CAS  Google Scholar 

  17. K. O. Hamilton G. Backstrom M. A. Yazdanian K. L. Audus (2001) ArticleTitleP-glycoprotein efflux pump expression and activity in Calu-3 cells J. Pharm. Sci. 90 647–658 Occurrence Handle11288109 Occurrence Handle1:CAS:528:DC%2BD3MXjt1OlsLk%3D Occurrence Handle10.1002/1520-6017(200105)90:5<647::AID-JPS1021>3.0.CO;2-G

    Article  PubMed  CAS  Google Scholar 

  18. M. Qadir K. L. O'Loughlin S. M. Fricke N. A. Williamson W. R. Greco H. Minderman M. R. Baer (2005) ArticleTitleCyclosporin A is a broad-spectrum multidrug resistance modulator Clin. Cancer Res. 11 2320–2326 Occurrence Handle15788683 Occurrence Handle1:CAS:528:DC%2BD2MXisFaisr4%3D Occurrence Handle10.1158/1078-0432.CCR-04-1725

    Article  PubMed  CAS  Google Scholar 

  19. H. Koepsell B. M. Schmitt V. Gorboulev (2003) ArticleTitleOrganic cation transporters Rev. Physiol., Biochem. Pharmacol. 150 36–90 Occurrence Handle1:CAS:528:DC%2BD2cXjs1Wmsbw%3D

    CAS  Google Scholar 

  20. U. Bock T. Flototto E. Haltner (2004) ArticleTitleValidation of cell culture models for the intestine and the blood–brain barrier and comparison of drug permeation ALTEX 21 IssueIDSuppl 3 57–64 Occurrence Handle15057409

    PubMed  Google Scholar 

  21. C. M. Incles C. M. Schultes H. Kempski H. Koehler L. R. Kelland S. Neidle (2004) ArticleTitleA G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells Mol. Cancer Ther. 3 1201–1206 Occurrence Handle15486186 Occurrence Handle1:CAS:528:DC%2BD2cXosVSrsrc%3D

    PubMed  CAS  Google Scholar 

  22. M. Loprevite R. E. Favoni A. Cupis Particlede P. Pirani F. Merlo F. Grossi A. Ardizzoni (1999) ArticleTitlePre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity Int. J. Oncol. 15 787–792 Occurrence Handle10493963 Occurrence Handle1:CAS:528:DyaK1MXntVSnsb8%3D

    PubMed  CAS  Google Scholar 

  23. J. A. Smith H. Ngo M. C. Martin J. K. Wolf (2005) ArticleTitleAn evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines Gynecol. Oncol. 98 141–145 Occurrence Handle15963813 Occurrence Handle1:CAS:528:DC%2BD2MXlt1GgtLg%3D Occurrence Handle10.1016/j.ygyno.2005.02.006

    Article  PubMed  CAS  Google Scholar 

  24. R. Ravizza M. B. Gariboldi L. Passarelli E. Monti (2004) ArticleTitleRole of the p53/p21 system in the response of human colon carcinoma cells to doxorubicin BMC Cancer 4 92 Occurrence Handle15601469 Occurrence Handle10.1186/1471-2407-4-92

    Article  PubMed  Google Scholar 

  25. S. Kobayashi S. Okada H. Yoshida S. Fujimura (1997) ArticleTitleIndomethacin enhances the cytotoxicity of VCR and ADR in human pulmonary adenocarcinoma cells Tohoku J. Exp. Med. 181 361–370 Occurrence Handle9163851 Occurrence Handle1:CAS:528:DyaK2sXis1eksLg%3D Occurrence Handle10.1620/tjem.181.361

    Article  PubMed  CAS  Google Scholar 

  26. S. Ong H. Liu X. Qiu G. Bhat C. Pidgeon (1995) ArticleTitleMembrane partition coefficients chromatographically measured using immobilized artificial membrane surfaces Anal. Chem. 67 755–762 Occurrence Handle7702190 Occurrence Handle1:CAS:528:DyaK2MXjtF2qsb4%3D Occurrence Handle10.1021/ac00100a011

    Article  PubMed  CAS  Google Scholar 

  27. C. Pidgeon S. Ong H. Liu X. Qiu M. Pidgeon A. H. Dantzig J. Munroe W. J. Hornback J. S. Kasher L. Glunz (1995) ArticleTitleIAM chromatography: an in vitro screen for predicting drug membrane permeability J. Med. Chem. 38 590–594 Occurrence Handle7861406 Occurrence Handle1:CAS:528:DyaK2MXjsFahsrc%3D Occurrence Handle10.1021/jm00004a004

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This project was financially supported by Deutsche Krebshilfe e.V., Bonn, Germany (project no.: 10-2035-Kl I) and by the Robert Bosch Foundation, Stuttgart, Germany.

Author information

Authors and Affiliations

  1. Biopharmaceutics and Pharmaceutical Technology, Saarland University, P.O. Box 15 11 50, 66041, Saarbrücken, Germany

    S. Taetz, C. Baldes, U. F. Schaefer & C.-M. Lehr

  2. Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany

    T. E. Mürdter, E. Kleideiter, K. Piotrowska & U. Klotz

  3. Across Barriers GmbH, Science Park Saar, Saarbrücken, Germany

    U. Bock, E. Haltner-Ukomadu & J. Mueller

  4. SHG Kliniken Völklingen, Center for Heart and Thoracic Surgery, Völklingen, Germany

    H. Huwer

Authors
  1. S. Taetz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Baldes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. E. Mürdter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Kleideiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Piotrowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. U. Bock
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Haltner-Ukomadu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. Mueller
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H. Huwer
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. U. F. Schaefer
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. U. Klotz
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. C.-M. Lehr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C.-M. Lehr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taetz, S., Baldes, C., Mürdter, T.E. et al. Biopharmaceutical Characterization of the Telomerase Inhibitor BRACO19. Pharm Res 23, 1031–1037 (2006). https://doi.org/10.1007/s11095-006-0026-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-006-0026-y

Key Words

Search

Navigation